Orencia

Medicinal product

(Invented) name

Orencia

Active substance (s)

Abataceptas

Strength

250 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AA24, Abatacept

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2007-05-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Abataceptas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
27605	30157	1030157	flakonas	milteliai ir švirkštas be silikono N1		Receptinis	EU/1/07/389/001	Tiekiama	-	-	No	-	-
27606	30158	1030158	flakonas	milteliai ir švirkštas be silikono N2		Receptinis	EU/1/07/389/002	Netiekiama	-	-	No	-	-
27607	30159	1030159	flakonas	milteliai ir švirkštas be silikono N3		Receptinis	EU/1/07/389/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-05-21	Registruotas